HK1088327A1 - Thiadiazine derivatives and use thereof as positive ampa receptor modulator - Google Patents

Thiadiazine derivatives and use thereof as positive ampa receptor modulator

Info

Publication number
HK1088327A1
HK1088327A1 HK06108870A HK06108870A HK1088327A1 HK 1088327 A1 HK1088327 A1 HK 1088327A1 HK 06108870 A HK06108870 A HK 06108870A HK 06108870 A HK06108870 A HK 06108870A HK 1088327 A1 HK1088327 A1 HK 1088327A1
Authority
HK
Hong Kong
Prior art keywords
receptor modulator
ampa receptor
thiadiazine derivatives
positive ampa
positive
Prior art date
Application number
HK06108870A
Other languages
English (en)
Inventor
Graindorge Emmanuel
Francotte Pierre
Boverie Stephane
De Tullio Pascal
Pirotte Bernard
Lestage Pierre
Danober Laurence
Renard Pierre
Caignard Daniel-Henri
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1088327A1 publication Critical patent/HK1088327A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK06108870A 2003-05-05 2006-08-10 Thiadiazine derivatives and use thereof as positive ampa receptor modulator HK1088327A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0305448A FR2854634B1 (fr) 2003-05-05 2003-05-05 Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2004/001070 WO2004099217A1 (fr) 2003-05-05 2004-05-04 Derives de thiadiazine et leur utilisation comme modulateurs positifs des recepteurs ampa

Publications (1)

Publication Number Publication Date
HK1088327A1 true HK1088327A1 (en) 2006-11-03

Family

ID=33306157

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06108870A HK1088327A1 (en) 2003-05-05 2006-08-10 Thiadiazine derivatives and use thereof as positive ampa receptor modulator

Country Status (21)

Country Link
US (1) US7476668B2 (uk)
EP (1) EP1620441A1 (uk)
JP (1) JP4461139B2 (uk)
KR (1) KR100741235B1 (uk)
CN (1) CN100363368C (uk)
AR (1) AR044245A1 (uk)
AU (1) AU2004236005B2 (uk)
BR (1) BRPI0410002A (uk)
CA (1) CA2524377C (uk)
EA (1) EA009240B1 (uk)
FR (1) FR2854634B1 (uk)
GE (1) GEP20084318B (uk)
HK (1) HK1088327A1 (uk)
MA (1) MA27732A1 (uk)
MX (1) MXPA05011823A (uk)
MY (1) MY136694A (uk)
NO (1) NO20055695L (uk)
NZ (1) NZ543214A (uk)
UA (1) UA80046C2 (uk)
WO (1) WO2004099217A1 (uk)
ZA (1) ZA200508660B (uk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005280058B2 (en) 2004-08-25 2010-09-02 Essentialis, Inc. Pharmaceutical formulations of potassium ATP channel openers and uses thereof
ES2374963T3 (es) 2006-01-05 2012-02-23 Essentialis, Inc. Sales de agentes de apertura del canal de potasio dependiente de atp y usos de las mismas.
WO2010054336A2 (en) * 2008-11-10 2010-05-14 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
WO2012020848A1 (en) 2010-08-10 2012-02-16 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
JP5901365B2 (ja) * 2012-03-12 2016-04-06 株式会社トクヤマ イミダート化合物の製造方法
AU2014277952A1 (en) 2013-06-13 2016-01-28 Veroscience Llc Compositions and methods for treating metabolic disorders
WO2017006931A1 (ja) 2015-07-06 2017-01-12 公立大学法人横浜市立大学 Ampa受容体に特異的に結合する新規化合物
JP6241974B1 (ja) 2017-01-11 2017-12-06 公立大学法人横浜市立大学 霊長類生体の脳内ampa受容体のイメージング方法、プログラム、及びスクリーニング方法
US10680583B1 (en) * 2019-02-26 2020-06-09 Xilinx, Inc. Control circuit for and method of controlling an operation of an integrated circuit device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3733409A (en) * 1969-05-20 1973-05-15 Schering Corp Method of treating hypertension using thieno (1,2,4) thiadiazines
WO1998012185A1 (en) * 1996-09-17 1998-03-26 The Regents Of The University Of California Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
PL338013A1 (en) * 1997-07-16 2000-09-25 Novo Nordisk As Derivatives of condensed 1,2,4-thiadiazine, their production and application
IL137720A0 (en) * 1998-02-18 2001-10-31 Neurosearch As Compounds and their use as positive ampa receptor modulators
FR2801587B1 (fr) * 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ZA200508660B (en) 2007-01-31
CA2524377A1 (fr) 2004-11-18
NZ543214A (en) 2009-02-28
MY136694A (en) 2008-11-28
EA200501696A1 (ru) 2006-06-30
BRPI0410002A (pt) 2006-04-25
AR044245A1 (es) 2005-09-07
CN1798750A (zh) 2006-07-05
CA2524377C (fr) 2010-08-24
GEP20084318B (en) 2008-03-10
US20070004709A1 (en) 2007-01-04
AU2004236005B2 (en) 2010-01-21
FR2854634B1 (fr) 2005-07-08
UA80046C2 (en) 2007-08-10
EA009240B1 (ru) 2007-12-28
JP4461139B2 (ja) 2010-05-12
NO20055695L (no) 2005-12-01
AU2004236005A1 (en) 2004-11-18
MXPA05011823A (es) 2006-05-25
KR20060006830A (ko) 2006-01-19
JP2006525292A (ja) 2006-11-09
EP1620441A1 (fr) 2006-02-01
MA27732A1 (fr) 2006-01-02
FR2854634A1 (fr) 2004-11-12
KR100741235B1 (ko) 2007-07-19
WO2004099217A1 (fr) 2004-11-18
CN100363368C (zh) 2008-01-23
US7476668B2 (en) 2009-01-13

Similar Documents

Publication Publication Date Title
HK1080846A1 (en) Benzoxazine derivatives as 5-ht6 modulators and uses thereof
HK1088327A1 (en) Thiadiazine derivatives and use thereof as positive ampa receptor modulator
IL185549A0 (en) Pyrimidine derivatives and their use as cb2 modulators
AU157771S (en) Orthotic
PL372123A1 (en) Thiazole derivatives
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
GB0219280D0 (en) Prosthesis
AP2004003110A0 (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
AU156929S (en) Orthotic
EP1530449A4 (en) ARTIFICIAL HORN SKIN
IL165924A0 (en) Indolin phenylsulfonamide derivatives
PL3002283T3 (pl) Pochodne tiazolu
IL172894A0 (en) Indol-6-sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
IL172891A0 (en) Indol-5-yl-sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
GB0315870D0 (en) Heterocyclic derivatives
IL166426A0 (en) N-biarylmethyl aminocycloalkanecarboxamide derivatives
AU2003266119A8 (en) Artificial joint
AU2003222659A8 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
IL158905A0 (en) Benzoxazepine derivatives and their use as ampa receptor stimulators
AU2003294938A8 (en) Epothilone derivatives
EP1531854A4 (en) O-DERIVATED NOCATHIACIN DERIVATIVES
GB0307231D0 (en) 7-Nitroindoline derivatives and their uses
AU2003243397A8 (en) Homo-camptothecin derivatives
GB0226609D0 (en) Heterocyclic derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120504